Engrail Therapeutics’ US$32 Million Extension Of Its Series A Financing

Hogan Lovells Engrail Therapeutics on the deal.Engrail Therapeutics recently completed US$32 million extension of its Series A financing round, bringing the total to US$64 million for…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now